Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder caused by mutations in the ACVRL1, ENG, and SMAD4 genes. HHT is commonly characterised by small arteriovenous malformations (AVMs) known as telangiectasias of the skin, oral or gastrointestinal mucosa, as well as larger AVMs of solid organs (lungs, liver, brain). However, the manifestations of HHT are extremely variable. Two patients with no family history of HHT and strikingly different clinical presentations, who are mosaic for mutations in the ACVRL1 or ENG gene, are reported here. These cases represent the first report of mosaicism in patients clinically affected with classical HHT and pulmonary arterial hypertension, and suggest the need for awareness of mosaicism when performing clinical testing for this disorder.
- pulmonary arterial hypertension
- cardiovascular medicine
- diagnostics tests
- molecular genetics
Statistics from Altmetric.com
Competing interests None.
Patient consent Obtained.
Ethics approval ARUP Laboratories has obtained approval from the University of Utah Institutional Review Board (IRB) to perform research studies and publish findings of these studies on patients who willingly sign the “Consent and Authorization for Publication of Personal Health Information” form. This approval was approved on 9/22/10. Signed consent forms have been submitted with our manuscript.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.